Skip to content

Non-Inferiority Trial Comparing Eurofarma's Experimental Product Saccharomyces Boulardii Versus Floratil® in the Prevention of Antibiotic-Associated Diarrhea

An Open-Label, Non-Inferiority, Phase III Trial Comparing Eurofarma's Experimental Product Saccharomyces Boulardii Versus Floratil® (S. Boulardii - Merck) in the Prevention of Antibiotic-Associated Diarrhea.

Status
Withdrawn
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01463943
Acronym
ACROSS
Enrollment
0
Registered
2011-11-02
Start date
2012-02-29
Completion date
2012-12-31
Last updated
2015-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotics

Brief summary

The study's objective is to evaluate the efficacy and safety of two formulations for the prophylactic treatment of diarrhea in subjects using antibiotics.

Interventions

OTHERProbiotic

Sponsors

Eurofarma Laboratorios S.A.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. ICF signature; 2. The subject must agree to follow the instructions and to perform study procedures and visits; 3. Male and female subjects between 18 and 65 years old; 4. Subjects who have scheduled a treatment or started the use of antibiotics over 24 hours ago:

Exclusion criteria

1. Generalized infection or bacteremia; 2. Chronic gastrointestinal diseases (e.g., Crohn's Disease and Irritable Bowel Syndrome); 3. Documented chronic diarrhea; 4. Acute diarrhea episode within 24 hours prior to the start of antibiotic use. Use of tube feeding (nasogastric and nasoenteral); 5. Immunodeficiency (radiotherapy or chemotherapy); 6. Use of food with probiotic properties in the last 10 days;

Design outcomes

Primary

MeasureTime frame
frequency of diarrhea in subjects using antibiotics

Secondary

MeasureTime frame
Frequency of diarrhea by severity

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026